Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19. (2020)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/19466315.2020.1790415
PubMed Identifier: 34191981
Publication URI: http://europepmc.org/abstract/MED/34191981
Type: Journal Article/Review
Volume: 12
Parent Publication: Statistics in biopharmaceutical research
Issue: 4
ISSN: 1946-6315